Cell fate‐inducing CARs orthogonally control multiple signaling pathways
Sign Up to like & getrecommendations! Published in 2022 at "Biotechnology Journal"
DOI: 10.1002/biot.202100463
Abstract: While chimeric antigen receptor (CAR) has been clinically applied in T cell‐mediated cancer therapy, CARs that combinatorially control general cell fates have yet to be practical. In this study, we aim to control multiple cell… read more here.
Keywords: cell fate; cell; fate inducing; control multiple ... See more keywords